109 related articles for article (PubMed ID: 15654600)
1. Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A).
Nakajou K; Horiuchi S; Sakai M; Haraguchi N; Tanaka M; Takeya M; Otagiri M
Diabetologia; 2005 Feb; 48(2):317-27. PubMed ID: 15654600
[TBL] [Abstract][Full Text] [Related]
2. CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells.
Nakajou K; Horiuchi S; Sakai M; Hirata K; Tanaka M; Takeya M; Kai T; Otagiri M
J Biochem; 2005 May; 137(5):607-16. PubMed ID: 15944414
[TBL] [Abstract][Full Text] [Related]
3. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
[TBL] [Abstract][Full Text] [Related]
4. Pathological roles of advanced glycation end product receptors SR-A and CD36.
Horiuchi S; Unno Y; Usui H; Shikata K; Takaki K; Koito W; Sakamoto Y; Nagai R; Makino K; Sasao A; Wada J; Makino H
Ann N Y Acad Sci; 2005 Jun; 1043():671-5. PubMed ID: 16037291
[TBL] [Abstract][Full Text] [Related]
5. Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A.
Matsumoto K; Sano H; Nagai R; Suzuki H; Kodama T; Yoshida M; Ueda S; Smedsrød B; Horiuchi S
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):233-40. PubMed ID: 11062078
[TBL] [Abstract][Full Text] [Related]
6. Mesangial accumulation of GA-pyridine, a novel glycolaldehyde-derived AGE, in human renal disease.
Greven WL; Waanders F; Nagai R; van den Heuvel MC; Navis G; van Goor H
Kidney Int; 2005 Aug; 68(2):595-602. PubMed ID: 16014036
[TBL] [Abstract][Full Text] [Related]
7. Glycolaldehyde-modified bovine serum albumin downregulates leptin expression in mouse adipocytes via a CD36-mediated pathway.
Unno Y; Sakai M; Sakamoto Y; Kuniyasu A; Nagai R; Nakayama H; Horiuchi S
Ann N Y Acad Sci; 2005 Jun; 1043():696-701. PubMed ID: 16037295
[TBL] [Abstract][Full Text] [Related]
8. The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs.
Nagai R; Mera K; Nakajou K; Fujiwara Y; Iwao Y; Imai H; Murata T; Otagiri M
Biochim Biophys Acta; 2007 Dec; 1772(11-12):1192-8. PubMed ID: 18053692
[TBL] [Abstract][Full Text] [Related]
9. Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.
Westwood ME; McLellan AC; Thornalley PJ
J Biol Chem; 1994 Dec; 269(51):32293-8. PubMed ID: 7798229
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacokinetics between highly and mildly modified AGE proteins in mice.
Nagai R; Mera K; Fujiwara Y; Nagai M; Otagiri M
Ann N Y Acad Sci; 2008 Apr; 1126():325-7. PubMed ID: 18079477
[TBL] [Abstract][Full Text] [Related]
11. Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins.
Takata K; Horiuchi S; Araki N; Shiga M; Saitoh M; Morino Y
J Biol Chem; 1988 Oct; 263(29):14819-25. PubMed ID: 2844787
[TBL] [Abstract][Full Text] [Related]
12. Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: the influence of charge density and size of the proteins molecules.
Yamasaki Y; Hisazumi J; Yamaoka K; Takakura Y
Eur J Pharm Sci; 2003 Apr; 18(5):305-12. PubMed ID: 12694882
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors.
Yamasaki Y; Sumimoto K; Nishikawa M; Yamashita F; Yamaoka K; Hashida M; Takakura Y
J Pharmacol Exp Ther; 2002 May; 301(2):467-77. PubMed ID: 11961045
[TBL] [Abstract][Full Text] [Related]
14. Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene.
Ling W; Lougheed M; Suzuki H; Buchan A; Kodama T; Steinbrecher UP
J Clin Invest; 1997 Jul; 100(2):244-52. PubMed ID: 9218499
[TBL] [Abstract][Full Text] [Related]
15. Effects of aldehyde-modified proteins on mesangial cell-matrix interaction.
Hasegawa G; Nakano K; Tsutsumi Y; Kondo M
Diabetes Res Clin Pract; 1994 Feb; 23(1):25-32. PubMed ID: 8013260
[TBL] [Abstract][Full Text] [Related]
16. Evidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells.
Neuwirth R; Singhal P; Diamond B; Hays RM; Lobmeyer L; Clay K; Schlondorff D
J Clin Invest; 1988 Sep; 82(3):936-44. PubMed ID: 3166467
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins.
Duryee MJ; Freeman TL; Willis MS; Hunter CD; Hamilton BC; Suzuki H; Tuma DJ; Klassen LW; Thiele GM
Mol Pharmacol; 2005 Nov; 68(5):1423-30. PubMed ID: 16105988
[TBL] [Abstract][Full Text] [Related]
18. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
[TBL] [Abstract][Full Text] [Related]
19. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.
Skolnik EY; Yang Z; Makita Z; Radoff S; Kirstein M; Vlassara H
J Exp Med; 1991 Oct; 174(4):931-9. PubMed ID: 1655949
[TBL] [Abstract][Full Text] [Related]
20. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
Usui HK; Shikata K; Sasaki M; Okada S; Matsuda M; Shikata Y; Ogawa D; Kido Y; Nagase R; Yozai K; Ohga S; Tone A; Wada J; Takeya M; Horiuchi S; Kodama T; Makino H
Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
